Effective post-exposure treatment of Ebola infection.

Ebola viruses are highly lethal human pathogens that have received considerable attention in recent years due to an increasing re-emergence in Central Africa and a potential for use as a biological weapon. There is no vaccine or treatment licensed for human use. In the past, however, important advan...

Full description

Bibliographic Details
Main Authors: Heinz Feldmann, Steven M Jones, Kathleen M Daddario-DiCaprio, Joan B Geisbert, Ute Ströher, Allen Grolla, Mike Bray, Elizabeth A Fritz, Lisa Fernando, Friederike Feldmann, Lisa E Hensley, Thomas W Geisbert
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2007-01-01
Series:PLoS Pathogens
Online Access:https://doi.org/10.1371/journal.ppat.0030002
id doaj-dc87aac089584cbe91e9faa77525e565
record_format Article
spelling doaj-dc87aac089584cbe91e9faa77525e5652021-04-21T17:09:33ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742007-01-0131e210.1371/journal.ppat.0030002Effective post-exposure treatment of Ebola infection.Heinz FeldmannSteven M JonesKathleen M Daddario-DiCaprioJoan B GeisbertUte StröherAllen GrollaMike BrayElizabeth A FritzLisa FernandoFriederike FeldmannLisa E HensleyThomas W GeisbertEbola viruses are highly lethal human pathogens that have received considerable attention in recent years due to an increasing re-emergence in Central Africa and a potential for use as a biological weapon. There is no vaccine or treatment licensed for human use. In the past, however, important advances have been made in developing preventive vaccines that are protective in animal models. In this regard, we showed that a single injection of a live-attenuated recombinant vesicular stomatitis virus vector expressing the Ebola virus glycoprotein completely protected rodents and nonhuman primates from lethal Ebola challenge. In contrast, progress in developing therapeutic interventions against Ebola virus infections has been much slower and there is clearly an urgent need to develop effective post-exposure strategies to respond to future outbreaks and acts of bioterrorism, as well as to treat laboratory exposures. Here we tested the efficacy of the vesicular stomatitis virus-based Ebola vaccine vector in post-exposure treatment in three relevant animal models. In the guinea pig and mouse models it was possible to protect 50% and 100% of the animals, respectively, following treatment as late as 24 h after lethal challenge. More important, four out of eight rhesus macaques were protected if treated 20 to 30 min following an otherwise uniformly lethal infection. Currently, this approach provides the most effective post-exposure treatment strategy for Ebola infections and is particularly suited for use in accidentally exposed individuals and in the control of secondary transmission during naturally occurring outbreaks or deliberate release.https://doi.org/10.1371/journal.ppat.0030002
collection DOAJ
language English
format Article
sources DOAJ
author Heinz Feldmann
Steven M Jones
Kathleen M Daddario-DiCaprio
Joan B Geisbert
Ute Ströher
Allen Grolla
Mike Bray
Elizabeth A Fritz
Lisa Fernando
Friederike Feldmann
Lisa E Hensley
Thomas W Geisbert
spellingShingle Heinz Feldmann
Steven M Jones
Kathleen M Daddario-DiCaprio
Joan B Geisbert
Ute Ströher
Allen Grolla
Mike Bray
Elizabeth A Fritz
Lisa Fernando
Friederike Feldmann
Lisa E Hensley
Thomas W Geisbert
Effective post-exposure treatment of Ebola infection.
PLoS Pathogens
author_facet Heinz Feldmann
Steven M Jones
Kathleen M Daddario-DiCaprio
Joan B Geisbert
Ute Ströher
Allen Grolla
Mike Bray
Elizabeth A Fritz
Lisa Fernando
Friederike Feldmann
Lisa E Hensley
Thomas W Geisbert
author_sort Heinz Feldmann
title Effective post-exposure treatment of Ebola infection.
title_short Effective post-exposure treatment of Ebola infection.
title_full Effective post-exposure treatment of Ebola infection.
title_fullStr Effective post-exposure treatment of Ebola infection.
title_full_unstemmed Effective post-exposure treatment of Ebola infection.
title_sort effective post-exposure treatment of ebola infection.
publisher Public Library of Science (PLoS)
series PLoS Pathogens
issn 1553-7366
1553-7374
publishDate 2007-01-01
description Ebola viruses are highly lethal human pathogens that have received considerable attention in recent years due to an increasing re-emergence in Central Africa and a potential for use as a biological weapon. There is no vaccine or treatment licensed for human use. In the past, however, important advances have been made in developing preventive vaccines that are protective in animal models. In this regard, we showed that a single injection of a live-attenuated recombinant vesicular stomatitis virus vector expressing the Ebola virus glycoprotein completely protected rodents and nonhuman primates from lethal Ebola challenge. In contrast, progress in developing therapeutic interventions against Ebola virus infections has been much slower and there is clearly an urgent need to develop effective post-exposure strategies to respond to future outbreaks and acts of bioterrorism, as well as to treat laboratory exposures. Here we tested the efficacy of the vesicular stomatitis virus-based Ebola vaccine vector in post-exposure treatment in three relevant animal models. In the guinea pig and mouse models it was possible to protect 50% and 100% of the animals, respectively, following treatment as late as 24 h after lethal challenge. More important, four out of eight rhesus macaques were protected if treated 20 to 30 min following an otherwise uniformly lethal infection. Currently, this approach provides the most effective post-exposure treatment strategy for Ebola infections and is particularly suited for use in accidentally exposed individuals and in the control of secondary transmission during naturally occurring outbreaks or deliberate release.
url https://doi.org/10.1371/journal.ppat.0030002
work_keys_str_mv AT heinzfeldmann effectivepostexposuretreatmentofebolainfection
AT stevenmjones effectivepostexposuretreatmentofebolainfection
AT kathleenmdaddariodicaprio effectivepostexposuretreatmentofebolainfection
AT joanbgeisbert effectivepostexposuretreatmentofebolainfection
AT utestroher effectivepostexposuretreatmentofebolainfection
AT allengrolla effectivepostexposuretreatmentofebolainfection
AT mikebray effectivepostexposuretreatmentofebolainfection
AT elizabethafritz effectivepostexposuretreatmentofebolainfection
AT lisafernando effectivepostexposuretreatmentofebolainfection
AT friederikefeldmann effectivepostexposuretreatmentofebolainfection
AT lisaehensley effectivepostexposuretreatmentofebolainfection
AT thomaswgeisbert effectivepostexposuretreatmentofebolainfection
_version_ 1714666546030182400